Last winter, public officials had to decide which groups would receive priority for the limited quantities of newly approved COVID-19 vaccines. A new USC Schaeffer Center study finds that how vaccines are allocated may contribute to vaccine hesitant individuals later refusing the vaccine when it is made available to them.

To continue reading this story, click here.